348 related articles for article (PubMed ID: 28345454)
21. Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinib.
Suda K; Tomizawa K; Fujii M; Murakami H; Osada H; Maehara Y; Yatabe Y; Sekido Y; Mitsudomi T
J Thorac Oncol; 2011 Jul; 6(7):1152-61. PubMed ID: 21597390
[TBL] [Abstract][Full Text] [Related]
22. A novel circ_MACF1/miR-942-5p/TGFBR2 axis regulates the functional behaviors and drug sensitivity in gefitinib-resistant non-small cell lung cancer cells.
Fan D; Yang Y; Zhang W
BMC Pulm Med; 2022 Jan; 22(1):27. PubMed ID: 34996416
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of MicroRNA-135 Promotes Sensitivity of Non-Small Cell Lung Cancer to Gefitinib by Targeting TRIM16.
Wang N; Zhang T
Oncol Res; 2018 Aug; 26(7):1005-1014. PubMed ID: 29295721
[TBL] [Abstract][Full Text] [Related]
24. MiR-153 inhibits the resistance of lung cancer to gefitinib via modulating expression of ABCE1.
Wang L; Lv X; Fu X; Su L; Yang T; Xu P
Cancer Biomark; 2019; 25(4):361-369. PubMed ID: 31306106
[TBL] [Abstract][Full Text] [Related]
25. MiR-130a overcomes gefitinib resistance by targeting met in non-small cell lung cancer cell lines.
Zhou YM; Liu J; Sun W
Asian Pac J Cancer Prev; 2014; 15(3):1391-6. PubMed ID: 24606471
[TBL] [Abstract][Full Text] [Related]
26. Depleting hsa_circ_0000567 suppresses acquired gefitinib resistance and proliferation of lung adenocarcinoma cells through regulating the miR-377-3p / ZFX axis: an in vitro and in vivo study.
Wang L; Li M; Lian R
Histol Histopathol; 2022 Jul; 37(7):637-654. PubMed ID: 35133000
[TBL] [Abstract][Full Text] [Related]
27. miR-365a-5p suppresses gefitinib resistance in non-small-cell lung cancer through targeting PELI3.
Li F; Li H; Li S; Lv B; Shi J; Yan H; Zhang H; He Y
Pharmacogenomics; 2020 Jul; 21(11):771-783. PubMed ID: 32635799
[No Abstract] [Full Text] [Related]
28. miR-124 modulates gefitinib resistance through SNAI2 and STAT3 in non-small cell lung cancer.
Hu FY; Cao XN; Xu QZ; Deng Y; Lai SY; Ma J; Hu JB
J Huazhong Univ Sci Technolog Med Sci; 2016 Dec; 36(6):839-845. PubMed ID: 27924500
[TBL] [Abstract][Full Text] [Related]
29. Suppression of Dicer increases sensitivity to gefitinib in human lung cancer cells.
Chen JC; Su YH; Chiu CF; Chang YW; Yu YH; Tseng CF; Chen HA; Su JL
Ann Surg Oncol; 2014 Dec; 21 Suppl 4():S555-63. PubMed ID: 24723223
[TBL] [Abstract][Full Text] [Related]
30. The long non-coding RNA SNHG5 regulates gefitinib resistance in lung adenocarcinoma cells by targetting
Wang Z; Pan L; Yu H; Wang Y
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29592872
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-125a-5p plays a role as a tumor suppressor in lung carcinoma cells by directly targeting STAT3.
Zhong L; Sun S; Shi J; Cao F; Han X; Chen Z
Tumour Biol; 2017 Jun; 39(6):1010428317697579. PubMed ID: 28631574
[TBL] [Abstract][Full Text] [Related]
32. [Screening and identification of microRNAs related to acquired gefitinib-resistance in lung adenocarcinoma cell lines].
Qin X; Liu B; Li Y; You J; Zhou Q
Zhongguo Fei Ai Za Zhi; 2011 Jun; 14(6):478-83. PubMed ID: 21645449
[TBL] [Abstract][Full Text] [Related]
33. FoxM1 mediated resistance to gefitinib in non-small-cell lung cancer cells.
Xu N; Zhang X; Wang X; Ge HY; Wang XY; Garfield D; Yang P; Song YL; Bai CX
Acta Pharmacol Sin; 2012 May; 33(5):675-81. PubMed ID: 22447226
[TBL] [Abstract][Full Text] [Related]
34. Comprehensive analysis of circular RNA profiling in AZD9291-resistant non-small cell lung cancer cell lines.
Chen T; Luo J; Gu Y; Huang J; Luo Q; Yang Y
Thorac Cancer; 2019 Apr; 10(4):930-941. PubMed ID: 30883029
[TBL] [Abstract][Full Text] [Related]
35. Expression Profiles of microRNAs in Drug-Resistant Non-Small Cell Lung Cancer Cell Lines Using microRNA Sequencing.
Hu S; Yuan Y; Song Z; Yan D; Kong X
Cell Physiol Biochem; 2018; 51(6):2509-2522. PubMed ID: 30557872
[TBL] [Abstract][Full Text] [Related]
36. 5-Aza-CdR can reverse gefitinib resistance caused by DAPK gene promoter methylation in lung adenocarcinoma cells.
Yang B; Yang ZG; Gao B; Shao GG; Li GH
Int J Clin Exp Pathol; 2015; 8(10):12961-6. PubMed ID: 26722491
[TBL] [Abstract][Full Text] [Related]
37. The long non-coding RNA, GAS5, enhances gefitinib-induced cell death in innate EGFR tyrosine kinase inhibitor-resistant lung adenocarcinoma cells with wide-type EGFR via downregulation of the IGF-1R expression.
Dong S; Qu X; Li W; Zhong X; Li P; Yang S; Chen X; Shao M; Zhang L
J Hematol Oncol; 2015 Apr; 8():43. PubMed ID: 25925741
[TBL] [Abstract][Full Text] [Related]
38. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K
Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317
[TBL] [Abstract][Full Text] [Related]
39. MiR-873 inhibition enhances gefitinib resistance in non-small cell lung cancer cells by targeting glioma-associated oncogene homolog 1.
Jin S; He J; Li J; Guo R; Shu Y; Liu P
Thorac Cancer; 2018 Oct; 9(10):1262-1270. PubMed ID: 30126075
[TBL] [Abstract][Full Text] [Related]
40. Long non-coding RNA H19 confers resistance to gefitinib via miR-148b-3p/DDAH1 axis in lung adenocarcinoma.
Huang Z; Ma Y; Zhang P; Si J; Xiong Y; Yang Y
Anticancer Drugs; 2020 Jan; 31(1):44-54. PubMed ID: 31503013
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
